The “Best Proven Therapeutic Method” Standard in Clinical Trials in Technologically Developing Countries

Journal of Clinical Ethics 9 (2):167-172 (1998)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1086/jce199809208

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Editorial: The "Best Proven Therapeutic Method" Standard in Clinical Trials in Technologically Developing Countries.Robert J. Levine - 1998 - IRB: Ethics & Human Research 20 (1):5.
Ethics status of clinical research and trials in developing countries.Yuanyuan Liu - 2015 - Eubios Journal of Asian and International Bioethics 25 (4):124-127.
Legal responses to placebo-controlled trials in developing countries.Ilja Richard Pavone - 2016 - Global Bioethics 27 (2-4):76-90.
The definition of adequate care in externally sponsored clinical trials: The terminological controversy about the concept “standard of care”.Hans-Jörg Ehni - 2006 - Science and Engineering Ethics 12 (1):123-130.
Issues of research ethics in developing world: Ways of improving the scenario.Amber Ali Muhammad - 2014 - Eubios Journal of Asian and International Bioethics 24 (2):66-68.
Commentary of "Placebo Studies in Developing Countries: Ethical, but not Ideal".Marilyn Eshikena - 2014 - Voices in Bioethics 1.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Clinical Trials and Scid Row: The Ethics of Phase 1 Trials in the Developing World.Jonathan Kimmelman - 2007 - Developing World Bioethics 7 (3):128-135.
The Ethics of Research in Lower Income Countries: Double Standards Are Not the Problem.David S. Wendler - 2017 - Journal of Clinical Ethics 28 (3):239-246.
Hegemony of economic values in conducting clinical trials with a placebo‐control group to investigate the treatment of periodontitis in lower‐middle‐income countries.Carlos M. Ardila & Constanza E. Ovalle - 2021 - Developing World Bioethics 22 (4):231-252.
Hegemony of economic values in conducting clinical trials with a placebo‐control group to investigate the treatment of periodontitis in lower‐middle‐income countries.Carlos M. Ardila & Constanza E. Ovalle - 2021 - Developing World Bioethics 22 (4):231-252.
Hegemony of economic values in conducting clinical trials with a placebo‐control group to investigate the treatment of periodontitis in lower‐middle‐income countries.Carlos M. Ardila & Constanza E. Ovalle - 2021 - Developing World Bioethics 22 (4):231-252.
Hegemony of economic values in conducting clinical trials with a placebo‐control group to investigate the treatment of periodontitis in lower‐middle‐income countries.Carlos M. Ardila & Constanza E. Ovalle - 2021 - Developing World Bioethics 22 (4):231-252.
Placebo orthodoxy and the double standard of care in multinational clinical research.Maya J. Goldenberg - 2015 - Theoretical Medicine and Bioethics 36 (1):7-23.
Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.Liza Dawson & Sheryl Zwerski - 2014 - Bioethics 29 (5):316-323.

Analytics

Added to PP
2023-06-14

Downloads
5 (#1,522,914)

6 months
4 (#790,778)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

The Vulnerable and the Susceptible.Michael H. Kottow - 2003 - Bioethics 17 (5-6):460-471.

View all 6 citations / Add more citations

References found in this work

No references found.

Add more references